Literature DB >> 27596220

[Improved survival in patients with prostate cancer].

René Baumann1, Jürgen Dunst2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27596220     DOI： 10.1007/s00066-016-1045-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

Review 1.  Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.

Authors:  Christopher E Bayne; Stephen B Williams; Matthew R Cooperberg; Martin E Gleave; Markus Graefen; Francesco Montorsi; Giacomo Novara; Marc C Smaldone; Prasanna Sooriakumaran; Peter N Wiklund; Brian F Chapin
Journal:  Eur Urol       Date:  2015-05-21       Impact factor: 20.096

2.  Role of radical prostatectomy in metastatic prostate cancer: data from the Munich Cancer Registry.

Authors:  Christian Gratzke; Jutta Engel; Christian G Stief
Journal:  Eur Urol       Date:  2014-05-10       Impact factor: 20.096

3.  Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.

Authors:  Chad G Rusthoven; Bernard L Jones; Thomas W Flaig; E David Crawford; Matthew Koshy; David J Sher; Usama Mahmood; Ronald C Chen; Brian F Chapin; Brian D Kavanagh; Thomas J Pugh
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

4.  Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.

Authors:  Raj Satkunasivam; Andre E Kim; Mihir Desai; Mike M Nguyen; David I Quinn; Leslie Ballas; Juan Pablo Lewinger; Mariana C Stern; Ann S Hamilton; Monish Aron; Inderbir S Gill
Journal:  J Urol       Date:  2015-02-21       Impact factor: 7.450

5.  Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.

Authors:  Stephen H Culp; Paul F Schellhammer; Michael B Williams
Journal:  Eur Urol       Date:  2013-11-20       Impact factor: 20.096

6.  Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.

Authors:  Rajendra Badwe; Rohini Hawaldar; Nita Nair; Rucha Kaushik; Vani Parmar; Shabina Siddique; Ashwini Budrukkar; Indraneel Mittra; Sudeep Gupta
Journal:  Lancet Oncol       Date:  2015-09-09       Impact factor: 41.316

7.  Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study.

Authors:  Nicola Fossati; Quoc-Dien Trinh; Jesse Sammon; Akshay Sood; Alessandro Larcher; Maxine Sun; Pierre Karakiewicz; Giorgio Guazzoni; Francesco Montorsi; Alberto Briganti; Mani Menon; Firas Abdollah
Journal:  Eur Urol       Date:  2014-09-10       Impact factor: 20.096
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.